Effectiveness of mRNA COVID-19 Vaccines and Hybrid Immunity in Preventing SARS-CoV-2 Infection and Symptomatic COVID-19 Among Adults in the United States.
Saved in:
| Title: | Effectiveness of mRNA COVID-19 Vaccines and Hybrid Immunity in Preventing SARS-CoV-2 Infection and Symptomatic COVID-19 Among Adults in the United States. |
|---|---|
| Authors: | Feldstein LR; Coronavirus and Other Respiratory Viruses Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia., Ruffin J; Coronavirus and Other Respiratory Viruses Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia., Wiegand RE; Coronavirus and Other Respiratory Viruses Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia., Borkowf CB; Coronavirus and Other Respiratory Viruses Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia., James-Gist J; Coronavirus and Other Respiratory Viruses Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia., Babu TM; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington., Briggs-Hagen M; Coronavirus and Other Respiratory Viruses Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia., Chappell J; Vanderbilt University Medical Center, Nashville, Tennessee., Chu HY; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington., Englund JA; Department of Pediatrics, University of Washington, Seattle Children's Research Institute, Seattle, Washington., Kuntz JL; Kaiser Permanente Center for Health Research, Portland, Oregon., Lauring AS; Division of Infectious Diseases, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan., Lo N; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington., Carone M; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington., Lockwood C; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington., Martin ET; Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, Michigan., Midgley CM; Coronavirus and Other Respiratory Viruses Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia., Monto AS; Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, Michigan., Naleway AL; Kaiser Permanente Center for Health Research, Portland, Oregon., Ogilvie T; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington., Saydah S; Coronavirus and Other Respiratory Viruses Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia., Schmidt MA; Kaiser Permanente Center for Health Research, Portland, Oregon., Schmitz JE; Vanderbilt University Medical Center, Nashville, Tennessee., Smith N; Kaiser Permanente Center for Health Research, Portland, Oregon., Sohn I; Vanderbilt University Medical Center, Nashville, Tennessee., Starita L; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington., Talbot HK; Vanderbilt University Medical Center, Nashville, Tennessee., Weil AA; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington., Grijalva CG; Vanderbilt University Medical Center, Nashville, Tennessee. |
| Source: | The Journal of infectious diseases [J Infect Dis] 2025 Apr 15; Vol. 231 (4), pp. e743-e753. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN: 1537-6613 (Electronic) Linking ISSN: 00221899 NLM ISO Abbreviation: J Infect Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39774936 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Effectiveness of mRNA COVID-19 Vaccines and Hybrid Immunity in Preventing SARS-CoV-2 Infection and Symptomatic COVID-19 Among Adults in the United States. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Feldstein+LR%22">Feldstein LR</searchLink>; Coronavirus and Other Respiratory Viruses Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.<br /><searchLink fieldCode="AU" term="%22Ruffin+J%22">Ruffin J</searchLink>; Coronavirus and Other Respiratory Viruses Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.<br /><searchLink fieldCode="AU" term="%22Wiegand+RE%22">Wiegand RE</searchLink>; Coronavirus and Other Respiratory Viruses Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.<br /><searchLink fieldCode="AU" term="%22Borkowf+CB%22">Borkowf CB</searchLink>; Coronavirus and Other Respiratory Viruses Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.<br /><searchLink fieldCode="AU" term="%22James-Gist+J%22">James-Gist J</searchLink>; Coronavirus and Other Respiratory Viruses Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.<br /><searchLink fieldCode="AU" term="%22Babu+TM%22">Babu TM</searchLink>; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington.<br /><searchLink fieldCode="AU" term="%22Briggs-Hagen+M%22">Briggs-Hagen M</searchLink>; Coronavirus and Other Respiratory Viruses Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.<br /><searchLink fieldCode="AU" term="%22Chappell+J%22">Chappell J</searchLink>; Vanderbilt University Medical Center, Nashville, Tennessee.<br /><searchLink fieldCode="AU" term="%22Chu+HY%22">Chu HY</searchLink>; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington.<br /><searchLink fieldCode="AU" term="%22Englund+JA%22">Englund JA</searchLink>; Department of Pediatrics, University of Washington, Seattle Children's Research Institute, Seattle, Washington.<br /><searchLink fieldCode="AU" term="%22Kuntz+JL%22">Kuntz JL</searchLink>; Kaiser Permanente Center for Health Research, Portland, Oregon.<br /><searchLink fieldCode="AU" term="%22Lauring+AS%22">Lauring AS</searchLink>; Division of Infectious Diseases, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan.<br /><searchLink fieldCode="AU" term="%22Lo+N%22">Lo N</searchLink>; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington.<br /><searchLink fieldCode="AU" term="%22Carone+M%22">Carone M</searchLink>; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington.<br /><searchLink fieldCode="AU" term="%22Lockwood+C%22">Lockwood C</searchLink>; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington.<br /><searchLink fieldCode="AU" term="%22Martin+ET%22">Martin ET</searchLink>; Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, Michigan.<br /><searchLink fieldCode="AU" term="%22Midgley+CM%22">Midgley CM</searchLink>; Coronavirus and Other Respiratory Viruses Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.<br /><searchLink fieldCode="AU" term="%22Monto+AS%22">Monto AS</searchLink>; Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, Michigan.<br /><searchLink fieldCode="AU" term="%22Naleway+AL%22">Naleway AL</searchLink>; Kaiser Permanente Center for Health Research, Portland, Oregon.<br /><searchLink fieldCode="AU" term="%22Ogilvie+T%22">Ogilvie T</searchLink>; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington.<br /><searchLink fieldCode="AU" term="%22Saydah+S%22">Saydah S</searchLink>; Coronavirus and Other Respiratory Viruses Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.<br /><searchLink fieldCode="AU" term="%22Schmidt+MA%22">Schmidt MA</searchLink>; Kaiser Permanente Center for Health Research, Portland, Oregon.<br /><searchLink fieldCode="AU" term="%22Schmitz+JE%22">Schmitz JE</searchLink>; Vanderbilt University Medical Center, Nashville, Tennessee.<br /><searchLink fieldCode="AU" term="%22Smith+N%22">Smith N</searchLink>; Kaiser Permanente Center for Health Research, Portland, Oregon.<br /><searchLink fieldCode="AU" term="%22Sohn+I%22">Sohn I</searchLink>; Vanderbilt University Medical Center, Nashville, Tennessee.<br /><searchLink fieldCode="AU" term="%22Starita+L%22">Starita L</searchLink>; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington.<br /><searchLink fieldCode="AU" term="%22Talbot+HK%22">Talbot HK</searchLink>; Vanderbilt University Medical Center, Nashville, Tennessee.<br /><searchLink fieldCode="AU" term="%22Weil+AA%22">Weil AA</searchLink>; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington.<br /><searchLink fieldCode="AU" term="%22Grijalva+CG%22">Grijalva CG</searchLink>; Vanderbilt University Medical Center, Nashville, Tennessee. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220413675%22">The Journal of infectious diseases</searchLink> [J Infect Dis] 2025 Apr 15; Vol. 231 (4), pp. e743-e753. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0413675 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1537-6613 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200221899%22">00221899 </searchLink><i>NLM ISO Abbreviation: </i>J Infect Dis <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39774936 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1093/infdis/jiaf007 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e743 Titles: – TitleFull: Effectiveness of mRNA COVID-19 Vaccines and Hybrid Immunity in Preventing SARS-CoV-2 Infection and Symptomatic COVID-19 Among Adults in the United States. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Feldstein LR – PersonEntity: Name: NameFull: Ruffin J – PersonEntity: Name: NameFull: Wiegand RE – PersonEntity: Name: NameFull: Borkowf CB – PersonEntity: Name: NameFull: James-Gist J – PersonEntity: Name: NameFull: Babu TM – PersonEntity: Name: NameFull: Briggs-Hagen M – PersonEntity: Name: NameFull: Chappell J – PersonEntity: Name: NameFull: Chu HY – PersonEntity: Name: NameFull: Englund JA – PersonEntity: Name: NameFull: Kuntz JL – PersonEntity: Name: NameFull: Lauring AS – PersonEntity: Name: NameFull: Lo N – PersonEntity: Name: NameFull: Carone M – PersonEntity: Name: NameFull: Lockwood C – PersonEntity: Name: NameFull: Martin ET – PersonEntity: Name: NameFull: Midgley CM – PersonEntity: Name: NameFull: Monto AS – PersonEntity: Name: NameFull: Naleway AL – PersonEntity: Name: NameFull: Ogilvie T – PersonEntity: Name: NameFull: Saydah S – PersonEntity: Name: NameFull: Schmidt MA – PersonEntity: Name: NameFull: Schmitz JE – PersonEntity: Name: NameFull: Smith N – PersonEntity: Name: NameFull: Sohn I – PersonEntity: Name: NameFull: Starita L – PersonEntity: Name: NameFull: Talbot HK – PersonEntity: Name: NameFull: Weil AA – PersonEntity: Name: NameFull: Grijalva CG IsPartOfRelationships: – BibEntity: Dates: – D: 15 M: 04 Text: 2025 Apr 15 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1537-6613 Numbering: – Type: volume Value: 231 – Type: issue Value: 4 Titles: – TitleFull: The Journal of infectious diseases Type: main |
| ResultId | 1 |